Eraky Akram M, Feller Christina, Tolba Hatem, Porwal Mokshal, Sacho Raphael H, Hedayat Hirad
Department of Neurosurgery, Medical College of Wisconsin, WI, USA.
Department of Neurology, Medical College of Wisconsin, Wauwatosa, WI, USA.
J Cerebrovasc Endovasc Neurosurg. 2024 Mar;26(1):58-64. doi: 10.7461/jcen.2023.E2023.04.001. Epub 2023 Aug 22.
The Pipeline Embolization Device (PED) is a flow-diverting intraluminal device that is approved for use in adults 18 years or older with internal carotid artery aneurysms. However, it can also be used off-label in pediatric patients with aneurysms that cannot be resolved with traditional endovascular treatments. Herein, we present two cases of flow diversion in the pediatric population with complete obliteration of the aneurysm and excellent outcomes. Flow diversion has been shown to be a safe endovascular option in treating complex aneurysms in children. Larger-sized, multicenter trials are encouraged to compare outcomes between flow diversion and other aneurysm treatment options given the rarity of pediatric aneurysms.
管道栓塞装置(PED)是一种血流导向腔内装置,已被批准用于治疗18岁及以上患有颈内动脉瘤的成年人。然而,它也可在标签外用于患有无法通过传统血管内治疗解决的动脉瘤的儿科患者。在此,我们报告两例儿科患者的血流导向治疗病例,动脉瘤完全闭塞且预后良好。血流导向已被证明是治疗儿童复杂动脉瘤的一种安全的血管内选择。鉴于儿科动脉瘤的罕见性,鼓励开展更大规模的多中心试验,以比较血流导向与其他动脉瘤治疗方案的疗效。